GlassScriptPhysician profile
Petar N Novakovic
NPI 1255388831
$7,886.05
in general payments reported to CMS, 2019-2025
49 companies · $932 in 2025
The $932 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $698 · 2021: $1,816 · 2022: $1,339 · 2023: $1,365 · 2024: $991 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,244 · Education: $25.00 · Entertainment: $19.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,243.62 |
| Education | $25.00 |
| Entertainment | $19.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,287.04 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,606.84 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $383.31 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $379.10 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $280.40 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $228.70 | 2021-2024 | Jot Dx, Proclaim, Freestyle Libre 3 |
| Pfizer INC. | $196.00 | 2019-2025 | |
| Eisai INC. | $190.84 | 2021-2025 | |
| Amarin Pharma, INC. | $183.45 | 2019-2022 | |
| Lilly USA, LLC | $178.08 | 2020-2025 | Mounjaro, Jardiance |
| Nestle Healthcare Nutrition INC. | $158.07 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.03 | 2019-2023 | Jardiance |
| Aimmune Therapeutics, INC. | $150.91 | 2025 | Zenpep |
| Kowa Pharmaceuticals America, INC. | $142.67 | 2020-2022 | |
| Allergan, INC. | $101.64 | 2019-2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Petar Novakovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.